EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy ( FSHD )

Anika Varma iD, Michael S Todinca, Katy Eichinger, Susanne Heininger, Nuran Dilek, William Martens, Rabi Tawil, Jeffrey Statland iD, John T Kissel, Michael P McDermott, Chad Heatwole

Muscle & Nerve · 2024

DOI: 10.1002/mus.28031 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Anika Varma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health + Technology, University of Rochester, Rochester, New York, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims In preparation for clinical trials, it is important to better understand how disease burden changes over time in facioscapulohumeral muscular dystrophy (FSHD) and to assess the capability of select metrics to detect these changes. This study aims to evaluate FSHD disease progression over 1 year and to examine the sensitivity of several outcome measures in detecting changes during this interval.

Methods

We conducted a 12‐month prospective observational study of 41 participants with FSHD. Participants were evaluated at baseline, 6 months, and 12 months with serial strength testing (manual muscle testing or MMT and maximum voluntary isometric contraction testing or MVICT), functional testing (FSHD‐Composite Outcome Measure or FSHD‐COM, FSHD Clinical Severity Score or CSS, and FSHD Evaluation Score or FES), sleep and fatigue assessments, lean body mass measurements, respiratory testing, and the FSHD‐Health Index patient‐reported outcome. Changes in these outcome measures were assessed over the 12‐month period. Associations between changes in outcome measures and both age and sex were also examined.

Results

In a 12‐month period, FSHD participant function remained largely stable with a mild worsening of strength, measured by MMT and standardized MVICT scores, and a mild loss in lean body mass.

Discussion

The abilities and disease burden of adults with FSHD are largely static over a 12‐month period with participants demonstrating a mild average reduction in some measures of strength. Selection of patients, outcome measures, and trial duration should be carefully considered during the design and implementation of future clinical studies involving FSHD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralHumansAdultLongitudinal StudiesDisease ProgressionProspective StudiesOutcome Assessment, Health Care

Stichwörter der Autor:innen

FSHDclinical trialdisease progressionoutcome measuretherapeutics

Autor:innen und Institutionen

  • Center for Health + Technology, University of Rochester, Rochester, New York, USA.
  • Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Neurology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA.

ORCID-Profile: Anika Varma, Jeffrey Statland

Förderung

  • NIGMS NIH HHS
  • NIAMS NIH HHS
  • NIH HHS
  • Muscular Dystrophy Association
  • National Institutes of Health

Zitieren

APA

Varma, A., Todinca, M. S., Eichinger, K., Heininger, S., Dilek, N., Martens, W., Tawil, R., Statland, J., Kissel, J. T., McDermott, M. P., & Heatwole, C. (2024). A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy ( FSHD ). Muscle & Nerve. https://doi.org/10.1002/mus.28031

Vancouver

Varma A, Todinca MS, Eichinger K, Heininger S, Dilek N, Martens W, et al. A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy ( FSHD ). Muscle & Nerve. 2024. doi:10.1002/mus.28031

BibTeX
@article{Varma2024,
  author = {Varma, Anika and Todinca, Michael S and Eichinger, Katy and Heininger, Susanne and Dilek, Nuran and Martens, William and Tawil, Rabi and Statland, Jeffrey and Kissel, John T and McDermott, Michael P and Heatwole, Chad},
  title = {A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy ( FSHD )},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28031}
}
Kostenlos starten →